You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
生物股份(600201.SH):與國內領先的科研團隊共同成立了“內蒙古百年合成生物科技有限公司”
格隆匯 05-09 17:40

格隆匯5月9日丨生物股份(600201.SH)在互動平台表示,2023年公司將“率先進入生物技術、信息技術融合創新合成生物學時代;向多聯多價疫苗、迭代疫苗、數字化疫苗和新型藥物進軍,攻克非洲豬瘟疫苗百年難關;應用AI智能為養殖業提供疫病防控整體解決方案,以價值營銷為用户提質增效”作為公司發展戰略。作為戰略目標實現的路徑支撐,公司與國內領先的科研團隊共同成立了“內蒙古百年合成生物科技有限公司”。該創新平台搭建過程中建立了集成開發、聯合創新的研發體系,通過與合作伙伴分工合作、共創共享,快速實現科研突破。該平台內研發項目處於實驗室研究階段,產業化過程尚存在不確定性。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account